Transposon Therapeutics specializes in developing therapeutics for debilitating and life-threatening diseases.
Transposon Therapeutics has raised $22.0M in total funding. The most recent round was Grant. The last funding was announced in March 2026.
Transposon Therapeutics's investors include SV Health Investors, Canaan Partners, Advanced Research Projects Agency for Health, Alzheimer's Drug Discovery Foundation.
Transposon Therapeutics is headquartered in Westport, United States.
Transposon Therapeutics specializes in developing therapeutics for debilitating and life-threatening diseases.
Transposon Therapeutics is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Transposon Therapeutics — Funding & Investors." VCBacked, March 4, 2026, https://www.vcbacked.co/company/transposon-therapeutics. Accessed August 13, 2026.
VCBacked. (2026). Transposon Therapeutics — Funding & Investors. Retrieved August 13, 2026, from https://www.vcbacked.co/company/transposon-therapeutics
{{cite web |title=Transposon Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/transposon-therapeutics |website=VCBacked |access-date=August 13, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated